Studies have found that in obesity, there is impaired LPL activity and lipolysis, reducing the removal of postprandial FFAs and contributing to dyslipidemia through upregulated hepatic VLDL release which increases TG levels [23,56]. This evidence concerns the gene LPL and metabolic syndrome.